Engineering and Development

Management and Executive

Founder and CEO

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?

Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio?

Tempus AI price target raised by $15 at Guggenheim, here's why

Biostatistician II

Tempus AI is dedicated to advancing the healthcare industry through precision medicine and AI technology. They are seeking a Biostatistician II to collaborate with various teams to develop statistical analysis plans and execute studies with a high level of scientific integrity in oncology and cardiology.

Sign up with Google

Sign in with Google